These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4280945)

  • 1. [Streptococcus pyogenes: M protein and type specific vaccine (author's transl)].
    Havlícek J
    Cesk Epidemiol Mikrobiol Imunol; 1974 Mar; 23(2):114-27. PubMed ID: 4280945
    [No Abstract]   [Full Text] [Related]  

  • 2. [T-proteins of Streptococcus pyogenes. I. Communication: Preparation of a serological type specific T1-antigen by ion exchange chromatography and its characterization (author's transl)].
    Schmidt KH; Kühnemund O; Köhler W
    Zentralbl Bakteriol A; 1980; 246(4):475-88. PubMed ID: 6999791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological characteristics of heat-killed Streptococcus type 1--sonic fractions obtained by zonal fractionation.
    Pine L; Besdine R; Reeves M; Bradley G
    Microbios; 1971 Apr; 3(12):225-46. PubMed ID: 5005824
    [No Abstract]   [Full Text] [Related]  

  • 4. The antigenic heterogenity of M protein of Streptococcus pyogenes (type 24).
    Havlícek J; Alouf JE; Raynaud M
    Zentralbl Bakteriol Orig; 1970; 214(3):390-2. PubMed ID: 4994145
    [No Abstract]   [Full Text] [Related]  

  • 5. [The immunobiology of M-proteins of Streptococcus pyogenes. I. Isolation and purification of M-proteins from group A streptococci (Streptococcus pyogenes) type 1].
    Kühnemund O; Köhler W
    Allerg Immunol (Leipz); 1976; 22(2):171-8. PubMed ID: 136885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of the type specific M protein from toxic cross reactive antigens of group A streptococci.
    Beachey EH; Chiang EY; Seyer JM; Kang AH; Chiang TM; Stollerman GH
    Trans Assoc Am Physicians; 1977; 90():390-400. PubMed ID: 347677
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules.
    Manjula BN; Fischetti VA
    J Immunol; 1980 Jan; 124(1):261-7. PubMed ID: 6985640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Streptococcus pyogenes: preparation of type-specific antigen and titration of type-specific antibodies (author's transl)].
    Havlícek J
    Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):108-14. PubMed ID: 124221
    [No Abstract]   [Full Text] [Related]  

  • 9. [T-proteins of Streptococcus pyogenes. III. Communication: purification of T-proteins extracted with trypsin, pepsin and C-phage-associated lysin by means of immunochromatography (author's transl)].
    Schmidt KH; Köhler W
    Zentralbl Bakteriol A; 1981 Mar; 249(1):1-14. PubMed ID: 6168140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a Streptococcus pyogenes vaccine candidate based on the M protein PL1 epitope.
    Simerska P; Lu H; Toth I
    Bioorg Med Chem Lett; 2009 Feb; 19(3):821-4. PubMed ID: 19097790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proof of M-protein of Streptococcus pyogenes on the cell surface using immuno-freeze etching].
    Wagner M; Roth J; Wagner B; Meyer HW
    Z Allg Mikrobiol; 1974; 14(7):611-6. PubMed ID: 4618944
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antigenic heterogeneity of the M protein of Streptococcus pyogenes type 24].
    Havlícek J; Alouf JE; Raynaud M
    Ann Inst Pasteur (Paris); 1969 Dec; 117(6):745-55. PubMed ID: 4985083
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic research on specific and nonspecific basic protein antigens of the Streptococcus pyogenes type (group A). II. Precipitation and gel diffusion reactions. Immunogenic properties. Cutaneous allergy].
    Wahl R; Drach G
    Ann Inst Pasteur (Paris); 1965 Jun; 108(6):736-58. PubMed ID: 4954049
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preparation and homogeneity evaluation of T protein from Streptococcus pyogenes type 12].
    Ludwicka A
    Med Dosw Mikrobiol; 1978; 30(1):1-6. PubMed ID: 357865
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracellular antigens of Streptococcus pyogenes. Isolation by means of column chromatography.
    Havlícek J; Havlícková H
    Pathol Microbiol (Basel); 1972; 38(5):354-61. PubMed ID: 4630760
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical investigations of somatic and flagellar components of Pasteurella pseudotuberculosis].
    Ullmann U
    Zentralbl Bakteriol Orig A; 1971 Oct; 218(2):201-11. PubMed ID: 4403540
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes.
    Schulze K; Olive C; Ebensen T; Guzmán CA
    Vaccine; 2006 Aug; 24(35-36):6088-95. PubMed ID: 16828529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Purification and characterization of erythrogenic toxins. I. Investigation of erythrogenic toxin A produced by Streptococcus pyogenes strain NY-5 (author's transl)].
    Gerlach D; Knöll H; Köhler W
    Zentralbl Bakteriol A; 1980; 247(2):177-91. PubMed ID: 6775448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.